TRUE Private Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,853
| Closed | -$768K | – | 243 |
|
|
2022
Q4 | $768K | Buy |
5,853
+1,649
| +39% | +$217K | 0.12% | 87 |
|
|
2022
Q3 | $491K | Buy |
+4,204
| New | +$491K | 0.07% | 109 |
|
|
2021
Q1 | – | Sell |
-162
| Closed | -$24K | – | 449 |
|
|
2020
Q4 | $24K | Buy |
162
+12
| +8% | +$1.78K | ﹤0.01% | 428 |
|
|
2020
Q3 | $20K | Hold |
150
| – | – | ﹤0.01% | 413 |
|
|
2020
Q2 | $20K | Sell |
150
-52
| -26% | -$6.93K | ﹤0.01% | 411 |
|
|
2020
Q1 | $21K | Sell |
202
-4
| -2% | -$416 | ﹤0.01% | 379 |
|
|
2019
Q4 | $24K | Buy |
+206
| New | +$24K | ﹤0.01% | 463 |
|
|
2019
Q3 | – | Sell |
-56
| Closed | -$6K | – | 455 |
|
|
2019
Q2 | $6K | Buy |
+56
| New | +$6K | ﹤0.01% | 607 |
|
|
2018
Q4 | – | Sell |
-3,640
| Closed | -$444K | – | 557 |
|
|
2018
Q3 | $444K | Buy |
3,640
+483
| +15% | +$58.9K | 0.06% | 177 |
|
|
2018
Q2 | $347K | Sell |
3,157
-290
| -8% | -$31.9K | 0.05% | 196 |
|
|
2018
Q1 | $367K | Buy |
3,447
+306
| +10% | +$32.6K | 0.06% | 163 |
|
|
2017
Q4 | $335K | Buy |
+3,141
| New | +$335K | 0.06% | 172 |
|